Coenzyme Q10 therapy

Molecular Syndromology

Volumn 5, Issue 3-4, 2014, Pages 187-197

  Garrido Maraver, Juan ^a   Cordero, Mario D ^b,c   Oropesa Ávila, Manuel ^a   Fernández Vega, Alejandro ^a   De La Mata, Mario ^a   Delgado Pavón, Ana ^a   De Miguel, Manuel ^c   Pérez Calero, Carmen ^a   Villanueva Paz, Marina ^a   Cotán, David ^a   Sánchez Alcázar, José A ^a,b  

^a UNIVERSIDAD PABLO DE OLAVIDE   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c UNIVERSITY OF SEVILLE   (Spain)

Author keywords

Clinical indications; Pharmacokinetics

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; METOPROLOL; MEVINOLIN; PHENOTHIAZINE DERIVATIVE; PRAVASTATIN; PROPRANOLOL; TRICYCLIC ANTIDEPRESSANT AGENT; UBIDECARENONE; UBIQUINONE; WARFARIN; ACETYLSALICYLIC ACID; ANTIHYPERTENSIVE AGENT; INSULIN;

ABDOMINAL DISCOMFORT; AGING; ALZHEIMER DISEASE; ANOREXIA; ARTICLE; ASTHENOSPERMIA; ATAXIA; ATHEROSCLEROSIS; BIOENERGY; CARCINOGENESIS; CARDIOVASCULAR DISEASE; CELL FRACTIONATION; CELL METABOLISM; CELL TRANSPORT; CHEMOTHERAPY INDUCED NAUSEA AND VOMITING; CONCENTRATION (PARAMETERS); DIABETES MELLITUS; DIARRHEA; DIET SUPPLEMENTATION; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DNA DAMAGE; DOWN SYNDROME; DRUG ABSORPTION; DRUG DISTRIBUTION; DRUG ERUPTION; DRUG INDUCED HEADACHE; DRUG MECHANISM; DRUG UPTAKE; DYSLIPIDEMIA; ENCEPHALOMYOPATHY; FIBROMYALGIA; FRIEDREICH ATAXIA; GENE MUTATION; HEART FAILURE; HUMAN; HUNTINGTON CHOREA; HYPERTENSION; ISCHEMIC HEART DISEASE; MALE INFERTILITY; METABOLIC DISORDER; MIGRAINE; MITOCHONDRIAL MEMBRANE; MUSCLE DISEASE; NEOPLASM; OXIDATIVE STRESS; PARKINSON DISEASE; PERIODONTAL DISEASE; PREECLAMPSIA; PRIORITY JOURNAL; RECESSIVE INHERITANCE; SIGNAL TRANSDUCTION; TISSUE DISTRIBUTION; TREATMENT INDICATION; UBIDECARENONE DEFICIENCY; AUTOSOMAL RECESSIVE DISORDER; CEREBELLAR ATAXIA; CLINICAL TRIAL (TOPIC); ENZYME BLOOD LEVEL; ENZYME THERAPY; GENE EXPRESSION; GROWTH RETARDATION; INTRACELLULAR SIGNALING; LEIGH DISEASE; META ANALYSIS (TOPIC); MYOPATHY; NEPHROTIC SYNDROME; PREGNANCY; SEVERE INFANTILE MULTISYSTEMIC DISEASE; SUPPLEMENTATION; SYSTEMIC DISEASE; TOXICITY;

EID: 84903983784     PISSN: 16618769     EISSN: 16618777     Source Type: Journal    
DOI: 10.1159/000360101     Document Type: Article

References (127)

1. Adarsh K, Kaur H, Mohan V: Coenzyme Q 10 (CoQ 10) in isolated diastolic heart failure in hypertrophic cardiomyopathy (HCM). Biofactors 32: 145-149 (2008
2. Artuch R, Brea-Calvo G, Briones P, Aracil A, Galvan M, et al: Cerebellar ataxia with coenzyme Q 10 deficiency: Diagnosis and follow-up after coenzyme Q 10 supplementation. J Neurol Sci 246: 153-158 (2006 (Pubitemid 43815358)
3. Beal MF: Coenzyme Q 10 administration and its potential for treatment of neurodegenerative diseases. Biofactors 9: 261-266 (1999 (Pubitemid 29289005)
4. Belardinelli R, Mucaj A, Lacalaprice F, Solenghi M, Seddaiu G, et al: Coenzyme Q 10 and exercise training in chronic heart failure. Eur Heart J 27: 2675-2681 (2006 (Pubitemid 44729868)
5. Bentinger M, Tekle M, Dallner G: Coenzyme Q-biosynthesis and functions. Biochem Biophys Res Commun 396: 74-79 (2010
6. Berbel-Garcia A, Barbera-Farre JR, Etessam JP, Salio AM, Cabello A, et al: Coenzyme Q 10 improves lactic acidosis, strokelike episodes, and epilepsy in a patient with MELAS (mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes). Clin Neuropharmacol 27: 187-191 (2004 (Pubitemid 39121732)
7. Bhagavan HN, Chopra RK: Coenzyme Q 10: Absorption, tissue uptake, metabolism and pharmacokinetics. Free Radic Res 40: 445-453 (2006
8. Bonakdar RA, Guarneri E: Coenzyme Q 10 . Am Fam Physician 72: 1065-1070 (2005
9. Brea-Calvo G, Rodriguez-Hernandez A, Fernandez-Ayala DJ, Navas P, Sanchez-Alcazar JA: Chemotherapy induces an increase in coenzyme Q 10 levels in cancer cell lines. Free Radic Biol Med 40: 1293-1302 (2006
10. Bresolin N, Doriguzzi C, Ponzetto C, Angelini C, Moroni I, et al: Ubidecarenone in the treatment of mitochondrial myopathies: A multicenter double-blind trial. J Neurol Sci 100: 70-78 (1990
11. Caso G, Kelly P, McNurlan MA, Lawson WE: Effect of coenzyme Q 10 on myopathic symptoms in patients treated with statins. Am J Cardiol 99: 1409-1412 (2007 (Pubitemid 46686635)
12. Celik T, Iyisoy A: Coenzyme Q 10 and coronary artery bypass surgery: What we have learned from clinical trials. J Cardiothorac Vasc Anesth 23: 935-936 (2009
13. Cooper JM, Schapira AH: Friedreich's ataxia: Coenzyme Q 10 and vitamin E therapy. Mitochondrion 7 Suppl: S127-135 (2007 (Pubitemid 46712240)
14. Cooper JM, Korlipara LV, Hart PE, Bradley JL, Schapira AH: Coenzyme Q 10 and vitamin E deficiency in Friedreich's ataxia: Predictor of efficacy of vitamin E and coenzyme Q 10 therapy. Eur J Neurol 15: 1371-1379 (2008
15. Cooper O, Seo H, Andrabi S, Guardia-Laguarta C, Graziotto J, et al: Pharmacological rescue of mitochondrial deficits in iPSC-derived neural cells from patients with familial Parkinson's disease. Sci Transl Med 4: 141ra190 (2012
16. Cordero MD, De Miguel M, Moreno Fernandez AM, Carmona Lopez IM, Garrido Maraver J, et al: Mitochondrial dysfunction and mitophagy activation in blood mononuclear cells of fibromyalgia patients: Implications in the pathogenesis of the disease. Arthritis Res Ther 12: R17 (2010
17. Cordero MD, Alcocer-Gomez E, de Miguel M, Cano-Garcia FJ, Luque CM, et al: Coenzyme Q 10: A novel therapeutic approach for Fibromyalgia? Case series with 5 patients. Mitochondrion 11: 623-625 (2011
18. Cordero MD, Cano-Garcia FJ, Alcocer-Gomez E, De Miguel M, Sanchez-Alcazar JA: Oxidative stress correlates with headache symptoms in fibromyalgia: Coenzyme Q 10 effect on clinical improvement. PLoS One 7: E35677 (2012
19. Cotan D, Cordero MD, Garrido-Maraver J, Oropesa-Avila M, Rodriguez-Hernandez A, et al: Secondary coenzyme Q 10 deficiency triggers mitochondria degradation by mitophagy in MELAS fibroblasts. FASEB J 25: 2669-2687 (2011
20. Crane FL: Biochemical functions of coenzyme Q 10 . J Am Coll Nutr 20: 591-598 (2001
21. Chen RS, Huang CC, Chu NS: Coenzyme Q 10 treatment in mitochondrial encephalomyopathies. Short-Term double-blind, crossover study. Eur Neurol 37: 212-218 (1997
22. De la Mata M, Garrido-Maraver J, Cotan D, Cordero MD, Oropesa-Avila M, et al: Recovery of MERRF fibroblasts and cybrids pathophysiology by Coenzyme Q 10 . Neurotherapeutics 9: 446-463 (2012
23. Di Giovanni S, Mirabella M, Spinazzola A, Crociani P, Silvestri G, et al: Coenzyme Q 10 reverses pathological phenotype and reduces apoptosis in familial CoQ 10 deficiency. Neurology 57: 515-518 (2001 (Pubitemid 32757603)
24. DiMauro S, Quinzii CM, Hirano M: Mutations in coenzyme Q 10 biosynthetic genes. J Clin Invest 117: 587-589 (2007
25. Domae N, Sawada H, Matsuyama E, Konishi T, Uchino H: Cardiomyopathy and other chronic toxic effects induced in rabbits by doxorubicin and possible prevention by coenzyme Q 10 . Cancer Treat Rep 65: 79-91 (1981 (Pubitemid 11047822)
26. Emmanuele V, Lopez LC, Berardo A, Naini A, Tadesse S, et al: Heterogeneity of coenzyme Q 10 deficiency: Patient study and literature review. Arch Neurol 69: 978-983 (2012
27. Folkers K, Littarru GP, Ho L, Runge TM, Havanonda S, Cooley D: Evidence for a deficiency of coenzyme Q 10 in human heart disease. Int Z Vitaminforsch 40: 380-390 (1970
28. Folkers K, Vadhanavikit S, Mortensen SA: Biochemical rationale and myocardial tissue data on the effective therapy of cardiomyopathy with coenzyme Q 10 . Proc Natl Acad Sci USA 82: 901-904 (1985a (Pubitemid 15142785)
29. Folkers K, Wolaniuk J, Simonsen R, Morishita M, Vadhanavikit S: Biochemical rationale and the cardiac response of patients with muscle disease to therapy with coenzyme Q 10 . Proc Natl Acad Sci USA 82: 4513-4516 (1985b (Pubitemid 15233150)
30. Galasko DR, Peskind E, Clark CM, Quinn JF, Ringman JM, et al: Antioxidants for Alzheimer disease: A randomized clinical trial with cerebrospinal fluid biomarker measures. Arch Neurol 69: 836-841 (2012
31. Garrido-Maraver J, Cordero MD, Monino ID, Pereira-Arenas S, Lechuga-Vieco AV, et al: Screening of effective pharmacological treatments for MELAS syndrome using yeasts, fibroblasts and cybrids models of the disease. Br J Pharmacol 167: 1311-1328 (2012
32. Gempel K, Topaloglu H, Talim B, Schneiderat P, Schoser BG, et al: The myopathic form of coenzyme Q 10 deficiency is caused by mutations in the electron-Transferring-flavoprotein dehydrogenase (ETFDH) gene. Brain 130: 2037-2044 (2007 (Pubitemid 47236610)
33. Golbidi S, Ebadi SA, Laher I: Antioxidants in the treatment of diabetes. Curr Diabetes Rev 7: 106-125 (2011
34. Gold R, Seibel P, Reinelt G, Schindler R, Landwehr P, et al: Phosphorus magnetic resonance spectroscopy in the evaluation of mitochondrial myopathies: Results of a 6-month therapy study with coenzyme Q. Eur Neurol 36: 191-196 (1996 (Pubitemid 26187226)
35. Golomb BA, Evans MA, Dimsdale JE, White HL: Effects of statins on energy and fatigue with exertion: Results from a randomized controlled trial. Arch Intern Med 172: 1180-1182 (2012
36. Greenberg S, Frishman WH: Co-enzyme Q 10: A new drug for cardiovascular disease. J Clin Pharmacol 30: 596-608 (1990 (Pubitemid 20241466)
37. Groneberg DA, Kindermann B, Althammer M, Klapper M, Vormann J, et al: Coenzyme Q 10 affects expression of genes involved in cell signalling, metabolism and transport in human CaCo-2 cells. Int J Biochem Cell Biol 37: 1208-1218 (2005 (Pubitemid 40381197)
38. Haas RH: The evidence basis for coenzyme Q therapy in oxidative phosphorylation disease. Mitochondrion 7(suppl): S136-S145 (2007 (Pubitemid 46712239)
39. Hadj A, Pepe S, Rosenfeldt F: The clinical application of metabolic therapy for cardiovascular disease. Heart Lung Circ 16(suppl 3): S56-S64 (2007 (Pubitemid 47233294)
40. Hargreaves IP, Duncan AJ, Heales SJ, Land JM: The effect of HMG-CoA reductase inhibitors on coenzyme Q 10: Possible biochemical/clinical implications. Drug Saf 28: 659-676 (2005 (Pubitemid 41132454)
41. Hart PE, Lodi R, Rajagopalan B, Bradley JL, Crilley JG, et al: Antioxidant treatment of patients with Friedreich ataxia: Four-year follow-up. Arch Neurol 62: 621-626 (2005 (Pubitemid 40489896)
42. Hathcock JN, Shao A: Risk assessment for coenzyme Q 10 (Ubiquinone). Regul Toxicol Pharmacol 45: 282-288 (2006
43. Henchcliffe C, Beal MF: Mitochondrial biology and oxidative stress in Parkinson disease pathogenesis. Nat Clin Pract Neurol 4: 600-609 (2008
44. Hernandez-Ojeda J, Cardona-Munoz EG, Roman-Pintos LM, Troyo-Sanroman R, Ortiz-Lazareno PC, et al: The effect of ubiquinone in diabetic polyneuropathy: A randomized double-blind placebo-controlled study. J Diabetes Complications 26: 352-358 (2012
45. Hershey AD, Powers SW, Vockell AL, Lecates SL, Ellinor PL, et al: Coenzyme Q 10 deficiency and response to supplementation in pediatric and adolescent migraine. Headache 47: 73-80 (2007 (Pubitemid 46096060)
46. Hidaka T, Fujii K, Funahashi I, Fukutomi N, Hosoe K: Safety assessment of coenzyme Q 10 (CoQ 10) . Biofactors 32: 199-208 (2008
47. Hodgson JM, Watts GF, Playford DA, Burke V, Croft KD: Coenzyme Q 10 improves blood pressure and glycaemic control: A controlled trial in subjects with type 2 diabetes. Eur J Clin Nutr 56: 1137-1142 (2002 (Pubitemid 35414801)
48. Horstink MW, van Engelen BG: The effect of coenzyme Q 10 therapy in Parkinson disease could be symptomatic. Arch Neurol 60: 1170-1172 (2003
49. Hosoe K, Kitano M, Kishida H, Kubo H, Fujii K, Kitahara M: Study on safety and bioavailability of ubiquinol (Kaneka QH) after single and 4-week multiple oral administration to healthy volunteers. Regul Toxicol Pharmacol 47: 19-28 (2007 (Pubitemid 44765121)
50. Jolliet P, Simon N, Barre J, Pons JY, Boukef M, et al: Plasma coenzyme Q 10 concentrations in breast cancer: Prognosis and therapeutic consequences. Int J Clin Pharmacol Ther 36: 506-509 (1998 (Pubitemid 28430238)
51. Kerr DS: Treatment of mitochondrial electron transport chain disorders: A review of clinical trials over the past decade. Mol Genet Metab 99: 246-255 (2010
52. Kishi T, Watanabe T, Folkers K: Bioenergetics in clinical medicine XV. Inhibition of coenzyme Q 10-enzymes by clinically used adrenergic blockers of beta-receptors. Res Commun Chem Pathol Pharmacol 17: 157-164 (1977 (Pubitemid 8112362)
53. Kwong LK, Kamzalov S, Rebrin I, Bayne AC, Jana CK, et al: Effects of coenzyme Q 10 administration on its tissue concentrations, mitochondrial oxidant generation, and oxidative stress in the rat. Free Radic Biol Med 33: 627-638 (2002 (Pubitemid 35245835)
54. Langsjoen H, Langsjoen P, Willis R, Folkers K: Usefulness of coenzyme Q 10 in clinical cardiology: A long-Term study. Mol Aspects Med 15(suppl): S165-S175 (1994a
55. Langsjoen P, Willis R, Folkers K: Treatment of essential hypertension with coenzyme Q 10 . Mol Aspects Med 15 Suppl: S265-272 (1994b
56. Lee BJ, Huang YC, Chen SJ, Lin PT: Coenzyme Q 10 supplementation reduces oxidative stress and increases antioxidant enzyme activity in patients with coronary artery disease. Nutrition 28: 250-255 (2012a
57. Lee BJ, Huang YC, Chen SJ, Lin PT: Effects of coenzyme Q 10 supplementation on inflammatory markers (high-sensitivity C-reactive protein, interleukin-6, and homocysteine) in patients with coronary artery disease. Nutrition 28: 767-772 (2012b
58. Lee J, Boo JH, Ryu H: The failure of mitochondria leads to neurodegeneration: Do mitochondria need a jump start? Adv Drug Deliv Rev 61: 1316-1323 (2009
59. Littarru GP, Tiano L: Bioenergetic and antioxidant properties of coenzyme Q 10: Recent developments. Mol Biotechnol 37: 31-37 (2007 (Pubitemid 350135901)
60. Littarru GP, Tiano L: Clinical aspects of coenzyme Q 10: An update. Nutrition 26: 250-254 (2010
61. Liu J, Wang L, Zhan SY, Xia Y: Coenzyme Q 10 for Parkinson's disease. Cochrane Database Syst Rev CD008150 (2011
62. Lockwood K, Moesgaard S, Hanioka T, Folkers K: Apparent partial remission of breast cancer in' high risk' patients supplemented with nutritional antioxidants, essential fatty acids and coenzyme Q 10 . Mol Aspects Med 15(suppl): S231-S240 (1994
63. Lonnrot K, Porsti I, Alho H, Wu X, Hervonen A, Tolvanen JP: Control of arterial tone after long-Term coenzyme Q 10 supplementation in senescent rats. Br J Pharmacol 124: 1500-1506 (1998 (Pubitemid 28360574)
64. Lopez-Lluch G, Rodriguez-Aguilera JC, Santos-Ocana C, Navas P: Is coenzyme Q a key factor in aging? Mech Ageing Dev 131: 225-235 (2010
65. Lynch DR, Perlman SL, Meier T: A phase 3, double-blind, placebo-controlled trial of idebenone in Friedreich ataxia. Arch Neurol 67: 941-947 (2010
66. Lyon W, Van den Brink O, Pepe S, Wowk M, Marasco S, Rosenfeldt FL: Similar therapeutic serum levels attained with emulsified and oilbased preparations of coenzyme Q 10 . Asia Pac J Clin Nutr 10: 212-215 (2001 (Pubitemid 33739358)
67. Mancini A, Balercia G: Coenzyme Q 10 in male infertility: Physiopathology and therapy. Biofactors 37: 374-380 (2011
68. Mancini A, De Marinis L, Oradei A, Hallgass ME, Conte G, et al: Coenzyme Q 10 concentrations in normal and pathological human seminal fluid. J Androl 15: 591-594 (1994
69. Mancini A, De Marinis L, Littarru GP, Balercia G: An update of Coenzyme Q 10 implications in male infertility: Biochemical and therapeutic aspects. Biofactors 25: 165-174 (2005 (Pubitemid 44070845)
70. Mancuso M, Orsucci D, Volpi L, Calsolaro V, Siciliano G: Coenzyme Q 10 in neuromuscular and neurodegenerative disorders. Curr Drug Targets 11: 111-121 (2010
71. Mas E, Mori TA: Coenzyme Q 10 and statin myalgia: What is the evidence? Curr Atheroscler Rep 12: 407-413 (2010
72. Miles MV: The uptake and distribution of coenzyme Q 10 . Mitochondrion 7(suppl): S72-S77 (2007
73. Miles MV, Patterson BJ, Schapiro MB, Hickey FJ, Chalfonte-Evans M, et al: Coenzyme Q 10 absorption and tolerance in children with Down syndrome: A dose-ranging trial. Pediatr Neurol 35: 30-37 (2006 (Pubitemid 43928477)
74. Miyake Y, Shouzu A, Nishikawa M, Yonemoto T, Shimizu H, et al: Effect of treatment with 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors on serum coenzyme Q 10 in diabetic patients. Arzneimittelforschung 49: 324-329 (1999 (Pubitemid 29198111)
75. Mohr D, Bowry VW, Stocker R: Dietary supplementation with coenzyme Q 10 results in increased levels of ubiquinol-10 within circulating lipoproteins and increased resistance of human low-density lipoprotein to the initiation of lipid peroxidation. Biochim Biophys Acta 1126: 247-254 (1992
76. Moreno-Fernandez AM, Cordero MD, Garrido-Maraver J, Alcocer-Gomez E, Casas-Barquero N, et al: Oral treatment with amitriptyline induces coenzyme Q deficiency and oxidative stress in psychiatric patients. J Psychiatr Res 46: 341-345 (2012
77. Mortensen SA: Overview on coenzyme Q 10 as adjunctive therapy in chronic heart failure. Rationale, design and end-points of 'Q-symbio'-A multinational trial. Biofactors 18: 79-89 (2003 (Pubitemid 38030702)
78. Mortensen SA, Leth A, Agner E, Rohde M: Doserelated decrease of serum coenzyme Q 10 during treatment with HMG-CoA reductase inhibitors. Mol Aspects Med 18(suppl): S137-S144 (1997
79. Muller T, Buttne T, Gholipour AF, Kuhn W: Coenzyme Q 10 supplementation provides mild symptomatic benefit in patients with Parkinson's disease. Neurosci Lett 341: 201-204 (2003 (Pubitemid 36403763)
80. Naia L, Ribeiro MJ, Rego AC: Mitochondrial and metabolic-based protective strategies in Huntington's disease: The case of creatine and coenzyme Q. Rev Neurosci 23: 13-28 (2011
81. Naini A, Lewis VJ, Hirano M, DiMauro S: Primary coenzyme Q 10 deficiency and the brain. Biofactors 18: 145-152 (2003
82. Noia G, Littarru GP, De Santis M, Oradei A, Mactromarino C, et al: Coenzyme Q 10 in pregnancy. Fetal Diagn Ther 11: 264-270 (1996
83. Ochiai A, Itagaki S, Kurokawa T, Kobayashi M, Hirano T, Iseki K: Improvement in intestinal coenzyme Q 10 absorption by food intake. Yakugaku Zasshi 127: 1251-1254 (2007 (Pubitemid 47204004)
84. Ogasahara S, Engel AG, Frens D, Mack D: Muscle coenzyme Q deficiency in familial mitochondrial encephalomyopathy. Proc Natl Acad Sci USA 86: 2379-2382 (1989 (Pubitemid 19102512)
85. Palamakula A, Soliman M, Khan MM: Regional permeability of coenzyme Q 10 in isolated rat gastrointestinal tracts. Pharmazie 60: 212-214 (2005 (Pubitemid 40461353)
86. Palan PR, Mikhail MS, Shaban DW, Romney SL: Plasma concentrations of coenzyme Q 10 and tocopherols in cervical intraepithelial neoplasia and cervical cancer. Eur J Cancer Prev 12: 321-326 (2003 (Pubitemid 36994088)
87. Pepe S, Marasco SF, Haas SJ, Sheeran FL, Krum H, Rosenfeldt FL: Coenzyme Q 10 in cardiovascular disease. Mitochondrion 7(suppl): S154-S167 (2007
88. Playford DA, Watts GF, Croft KD, Burke V: Combined effect of coenzyme Q 10 and fenofibrate on forearm microcirculatory function in type 2 diabetes. Atherosclerosis 168: 169-179 (2003 (Pubitemid 36555825)
89. Prakash S, Sunitha J, Hans M: Role of coenzyme Q 10 as an antioxidant and bioenergizer in periodontal diseases. Indian J Pharmacol 42: 334-337 (2010
90. Quinzii CM, Hirano M: Primary and secondary CoQ 10 deficiencies in humans. Biofactors 37: 361-365 (2011
91. Quinzii CM, Kattah AG, Naini A, Akman HO, Mootha VK, et al: Coenzyme Q deficiency and cerebellar ataxia associated with an aprataxin mutation. Neurology 64: 539-541 (2005 (Pubitemid 40189878)
92. Quinzii C, Naini A, Salviati L, Trevisson E, Navas P, et al: A mutation in para-hydroxybenzoatepolyprenyl transferase (COQ2) causes primary coenzyme Q 10 deficiency. Am J Hum Ge net 78: 345-349 (2006 (Pubitemid 43157573)
93. Quinzii CM, DiMauro S, Hirano M: Human coenzyme Q 10 deficiency. Neurochem Res 32: 723-727 (2007
94. Rodriguez-Hernandez A, Cordero MD, Salviati L, Artuch R, Pineda M, et al: Coenzyme Q deficiency triggers mitochondria degradation by mitophagy. Autophagy 5: 19-32 (2009
95. Roffe L, Schmidt K, Ernst E: Efficacy of coenzyme Q 10 for improved tolerability of cancer treatments: A systematic review. J Clin Oncol 22: 4418-4424 (2004 (Pubitemid 41185163)
96. Rosenfeldt FL, Haas SJ, Krum H, Hadj A, Ng K, et al: Coenzyme Q 10 in the treatment of hypertension: A meta-Analysis of the clinical trials. J Hum Hypertens 21: 297-306 (2007 (Pubitemid 46453530)
97. Rotig A, Appelkvist EL, Geromel V, Chretien D, Kadhom N, et al: Quinone-responsive multiple respiratory-chain dysfunction due to widespread coenzyme Q 10 deficiency. Lancet 356: 391-395 (2000 (Pubitemid 30487496)
98. Rotig A, Mollet J, Rio M, Munnich A: Infantile and pediatric quinone deficiency diseases. Mitochondrion 7(suppl): S112-S121 (2007 (Pubitemid 46712228)
99. Rozen TD, Oshinsky ML, Gebeline CA, Bradley KC, Young WB, et al: Open label trial of coenzyme Q 10 as a migraine preventive. Cephalalgia 22: 137-141 (2002 (Pubitemid 34494135)
100. Rusciani L, Proietti I, Rusciani A, Paradisi A, Sbordoni G, et al: Low plasma coenzyme Q 10 levels as an independent prognostic factor for melanoma progression. J Am Acad Dermatol 54: 234-241 (2006 (Pubitemid 43144392)
101. Sacconi S, Trevisson E, Salviati L, Ayme S, Rigal O, et al: Coenzyme Q 10 is frequently reduced in muscle of patients with mitochondrial myopathy. Neuromuscul Disord 20: 44-48 (2010
102. Safarinejad MR: The effect of coenzyme Q 10 supplementation on partner pregnancy rate in infertile men with idiopathic oligoasthenoteratozoospermia: An open-label prospective study. Int Urol Nephrol 44: 689-700 (2012
103. Salviati L, Sacconi S, Murer L, Zacchello G, Franceschini L, et al: Infantile encephalomyopathy and nephropathy with CoQ 10 deficiency: A CoQ 10-responsive condition. Neurology 65: 606-608 (2005 (Pubitemid 41170725)
104. Sander S, Coleman CI, Patel AA, Kluger J, White CM: The impact of coenzyme Q 10 on systolic function in patients with chronic heart failure. J Card Fail 12: 464-472 (2006 (Pubitemid 46106977)
105. Sandor PS, Di Clemente L, Coppola G, Saenger U, Fumal A, et al: Efficacy of coenzyme Q 10 in migraine prophylaxis: A randomized controlled trial. Neurology 64: 713-715 (2005 (Pubitemid 40261904)
106. Santos-Gonzalez M, Gomez Diaz C, Navas P, Villalba JM: Modifications of plasma proteome in long-lived rats fed on a coenzyme Q 10-supplemented diet. Exp Gerontol 42: 798-806 (2007 (Pubitemid 47064497)
107. Schmelzer C, Lindner I, Rimbach G, Niklowitz P, Menke T, Doring F: Functions of coenzyme Q 10 in inflammation and gene expression. Biofactors 32: 179-183 (2008
108. Serebruany VL, Ordonez JV, Herzog WR, Rohde M, Mortensen SA, et al: Dietary coenzyme Q 10 supplementation alters platelet size and inhibits human vitronectin (CD51/CD61) receptor expression. J Cardiovasc Pharmacol 29: 16-22 (1997 (Pubitemid 27045169)
109. Shults CW, Haas RH, Passov D, Beal MF: Coenzyme Q 10 levels correlate with the activities of complexes I and II/III in mitochondria from parkinsonian and nonparkinsonian subjects. Ann Neurol 42: 261-264 (1997 (Pubitemid 27340475)
110. Shults CW, Beal MF, Fontaine D, Nakano K, Haas RH: Absorption, tolerability, and effects on mitochondrial activity of oral coenzyme Q 10 in parkinsonian patients. Neurology 50: 793-795 (1998
111. Shults CW, Haas RH, Beal MF: A possible role of coenzyme Q 10 in the etiology and treatment of Parkinson's disease. Biofactors 9: 267-272 (1999 (Pubitemid 29289006)
112. Shults CW, Flint Beal M, Song D, Fontaine D: Pilot trial of high dosages of coenzyme Q 10 in patients with Parkinson's disease. Exp Neurol 188: 491-494 (2004 (Pubitemid 38891609)
113. Singh U, Devaraj S, Jialal I: Coenzyme Q 10 supplementation and heart failure. Nutr Rev 65: 286-293 (2007
114. Sohal RS, Forster MJ: Coenzyme Q, oxidative stress and aging. Mitochondrion 7(suppl): S103-S111 (2007 (Pubitemid 46712236)
115. Sohmiya M, Tanaka M, Tak NW, Yanagisawa M, Tanino Y, et al: Redox status of plasma coenzyme Q 10 indicates elevated systemic oxidative stress in Parkinson's disease. J Neurol Sci 223: 161-166 (2004 (Pubitemid 39164358)
116. Stack EC, Matson WR, Ferrante RJ: Evidence of oxidant damage in Huntington's disease: Translational strategies using antioxidants. Ann N Y Acad Sci 1147: 79-92 (2008
117. Teran E, Hernandez I, Nieto B, Tavara R, Ocampo JE, Calle A: Coenzyme Q 10 supplementation during pregnancy reduces the risk of pre-eclampsia. Int J Gynaecol Obstet 105: 43-45 (2009
118. Tiano L, Busciglio J: Mitochondrial dysfunction and Down's syndrome: Is there a role for coenzyme Q 10 ? Biofactors 37: 386-392 (2011
119. Tiano L, Carnevali P, Padella L, Santoro L, Principi F, et al: Effect of Coenzyme Q 10 in mitigating oxidative DNA damage in Down syndrome patients, a double blind randomized controlled trial. Neurobiol Aging 32: 2103-2105 (2011
120. Villalba JM, Parrado C, Santos-Gonzalez M, Alcain FJ: Therapeutic use of coenzyme Q 10 and coenzyme Q 10-related compounds and formulations. Expert Opin Investig Drugs 19: 535-554 (2010
121. Wadsworth TL, Bishop JA, Pappu AS, Woltjer RL, Quinn JF: Evaluation of coenzyme Q as an antioxidant strategy for Alzheimer's disease. J Alzheimers Dis 14: 225-234 (2008 (Pubitemid 352040040)
122. Watts GF, Playford DA, Croft KD, Ward NC, Mori TA, Burke V: Coenzyme Q 10 improves endothelial dysfunction of the brachial artery in type II diabetes mellitus. Diabetologia 45: 420-426 (2002 (Pubitemid 34267365)
123. Weber C, Bysted A, Holmer G: Intestinal absorption of coenzyme Q 10 administered in a meal or as capsules to healthy subjects. Nutr Res 17: 941-945 (1997 (Pubitemid 27185001)
124. Weis M, Mortensen SA, Rassing MR, Moller-Sonnergaard J, Poulsen G, Rasmussen SN: Bioavailability of four oral coenzyme Q 10 formulations in healthy volunteers. Mol Aspects Med 15(suppl): S273-S280 (1994
125. Witting PK, Pettersson K, Letters J, Stocker R: Anti-Atherogenic effect of coenzyme Q 10 in apolipoprotein E gene knockout mice. Free Radic Biol Med 29: 295-305 (2000
126. Wyman M, Leonard M, Morledge T: Coenzyme Q 10: A therapy for hypertension and statin-induced myalgia? Cleve Clin J Med 77: 435-442 (2010
127. Zhang Y, Aberg F, Appelkvist EL, Dallner G, Ernster L: Uptake of dietary coenzyme Q supplement is limited in rats. J Nutr 125: 446-453 (1995.